News
-
-
-
-
-
-
COMMUNIQUÉ RÉGLEMENTÉ
Statement of transactions in own shares from October 28, 2024 to November 1, 2024
-
COMMUNIQUÉ RÉGLEMENTÉ
Déclaration des transactions sur actions propres réalisées du 28/10/2024 au 01/11/2024
-
-
COMMUNIQUÉ DE PRESSE
Pentixapharm Welcomes CMS Decision to Enhance Reimbursement for Diagnostic Radiopharmaceuticals
Pentixapharm welcomes CMS decision to enhance reimbursement for diagnostic radiopharmaceuticals, which could impact future streams for Ga68-PentixaFor and have broader market implications -